Telix Pharma Ltd (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Telix Pharmaceuticals Ltd. - ADR: Is Infosys Ltd. worth buying?
Item: Telix Pharmaceuticals Ltd. - ADR
Rating: 1.27650
Author: Trendlyne DVM scores

about

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tom...

7.87 0.02 (0.25%)

60.51% Fall from 52W High

148.0K

XNAS Volume

XNAS 16 Mar, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.0 / 100

Technically Neutral

47.1 / 100

1Yr Price target upside is 169%

4 analysts

Telix Pharma Ltd (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Telix Pharma Ltd (ADR) Live Stock Price Today, Share Analysis and Chart

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tom...

60.51% Fall from 52W High

SWOT Analysis

Telix Pharma Ltd (ADR) Live Price Chart